Results 101 to 110 of about 23,528 (188)

Nanoshell Fabrication Techniques for Probiotic Encapsulation: A Comprehensive Review

eFood, Volume 7, Issue 3, June 2026.
ABSTRACT Probiotics, beneficial microorganisms, confer numerous health benefits when administered. However, their efficacy is hindered by harsh gut conditions, including acidity, bile acids, and enzymatic degradation. To overcome these challenges, encapsulation and nanoshell technology have emerged as a pivotal strategy to enhance probiotic stability ...
Tuba Mustafa, Muhammad Afzaal, Farhan Saeed, Amna Shahbaz, Zainab Hira, Ayesha Adil, Tayyaba Sohail, Faiyaz Ahmed, Maryam Amanullah, Hina Sarwar, Noor Akram, Saad Mansoor, Gebremichael Gebremedhin Hailu   +12 more
wiley   +1 more source

The Detection of Silent Celiac Disease In patients With Type 1 Diabetes Mellitus by the use of Anti Tissue Transglutaminase Antibodies

مجله كليه طب الكندي, 2012
Objective: Detection the presumptive prevalence of silent celiac disease in patients with type 1 diabetes mellitus with determination of which gender more likely to be affected.
Anower Tuama Obaid, Rushdi A.H. Kubba, Zaidan K. Al Hergani   +2 more
doaj  

Recent Progress on Enzyme Immobilization: Materials, Strategies, and Applications

Food Bioengineering, Volume 5, Issue 2, Page 220-243, June 2026.
Enzyme immobilization technology has undergone substantial evolution driven by advances in materials science. This review systematically examines the recent advances in enzyme immobilization since 2024, with a focused analysis of five major categories of enzyme carriers including covalent organic framework, metal‐organic frameworks, polymers, carbon ...
Shuran Wang, Ruoke Li, Yixuan Xie, Hanya Zhang, Xiaoyu Huang, Siwei Chen, Weixin Xu, Yueling Liu   +7 more
wiley   +1 more source

OV16 Improves Radiation-Induced Intestinal Injury by Targeting Transglutaminase 2. [PDF]

Molecules
Zhang Z, Wang H, Cui Y, Lu Y, Xu Y, Li M, Liu S, Tian Y, Xia Z, Zhang G, Liu S.   +10 more
europepmc   +1 more source

From Cell Line to Fillet: A Review of Biological and Engineering Strategies in Cultivated Seafood

Food Bioengineering, Volume 5, Issue 2, Page 259-277, June 2026.
Bottlenecks of the cultivated seafood industry are shown, and they prevent efficiency of key production stages. These include limited cell line availability, sustainable and cost‐effective media, adaption to suspension culture, sustainable cost‐effective and edible scaffolds, food regulatory approval and acceptance of genetic modified organisms (GMO ...
Angela Trace, Miriam Wankell, Craig McFarlane, Lionel Hebbard   +3 more
wiley   +1 more source

Transglutaminase 2 regulates innate immunity: mechanisms and therapeutic implications. [PDF]

Oncoimmunology
D'Eletto M, Occhigrossi L, Colasuonno F, Bellanca V, Di Sano F, Montesano C, Ciccosanti F, Shi Y, Piacentini M, Rossin F.   +9 more
europepmc   +1 more source

Guidelines for the preparation of hydrogels with protective function

Food Biomacromolecules, Volume 3, Issue 2, Page 341-351, June 2026.
Abstract As three dimensional network structure functional materials, protective hydrogels, with their excellent biocompatibility, high water content, and the ability to provide physical barriers and regulate the environment for active substances/cells, have shown broad prospects in fields such as drug delivery, tissue engineering, and food ...
Xiao‐Lin Yu, Hao‐Yu Xue, Nuo Wang, Zi‐Jun Xue, Jin‐Long Tian   +4 more
wiley   +1 more source

Myeloid transglutaminase 2 regulates Treg-Th17 balance in a female model of angiotensin II-induced hypertension and vascular stiffening. [PDF]

Am J Physiol Heart Circ Physiol
Naz H, Teixeiro E, Manrique-Acevedo C, Lastra G.   +3 more
europepmc   +1 more source

Multidisciplinary Strategies for Targeting Tumor Dormancy in Breast Cancer Therapeutics: Hallmarks, Mechanism, and Approaches

iMetaMed, Volume 2, Issue 2, June 2026.
Clinical phases and classification of breast tumor dormancy. Tumor dormancy is described as the period after treatment until residual tumor cells become detectable as relapsing disease in clinic. During the period of clinical tumor dormancy, tumor mass dormancy and cellular dormancy may coexist.
Shu Chen, Hui Chen, Vijaya Raghavan, Jing Huang, Jin Wang   +4 more
wiley   +1 more source

The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy models. [PDF]

Proc Natl Acad Sci U S A
Hassanzadeh K, Liu J, Zhang J, Tabari MA, Maddila S, Mouradian MM.   +5 more
europepmc   +1 more source